In one 2024 real-world study, 40% of GLP-1 patients had inadequate protein intake, and 25% had suboptimal vitamin D, B12, iron, or calcium within 3 months of starting therapy
To ensure the quality of the result, the researchers considered 59 factorsincluding obesity, medications, chronic diseasesthat could affect the aspiration risks and alter the findings
3 Today were taking an important next step toward building a better model of healthcare that works for everyday people, said Andrew Dudum, co-founder and CEO of Hims & Hers
Cell Metab 2023;35:287-98.ArticlePubMed 103
Blood Sugar and Cardiometabolic Benefits Beyond weight loss, orforglipron demonstrated significant improvements in glycemic control
A few changes in the world of GLP-1 agonists are making the drugs more accessible to people, even if their health care plans don't cover them